Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) - No Study Results Posted

Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) (SPERA)

This study is ongoing, but not recruiting participants.

Study NCT00450970 Information provided by GPC Biotech

First Received: March 20, 2007 Last Updated: January 8, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2007
Estimated Primary Completion Date:	No date given